This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Chandra Sekhar Korapala: Innovator in Pharmaceutical Compounds
Introduction
Chandra Sekhar Korapala is a distinguished inventor based in Bengaluru, India, recognized for his contributions to the field of pharmaceuticals. With a focus on developing innovative compounds, he has made a significant impact in medical research and treatment.
Latest Patents
Chandra holds a notable patent for "Pyrrolidine derived beta 3 adrenergic receptor agonists." This invention involves compounds of Formula (I), along with pharmaceutical compositions and methods for utilizing these compounds. The invention aims to treat or prevent diseases mediated by the activation of the β3-adrenoceptor, reflecting his commitment to addressing critical health challenges.
Career Highlights
Currently, Chandra Sekhar Korapala is employed at Merck Sharp & Dohme Corporation, a global leader in the pharmaceutical industry. His role involves extensive research and development, contributing to innovative therapies and advancements in drug formulation.
Collaborations
Throughout his career, Chandra has collaborated with esteemed colleagues, including Kenneth Jay Barr and Mark E Scott. These collaborations have fostered a dynamic environment for innovation, enhancing the potential for groundbreaking discoveries in pharmaceutical science.
Conclusion
Chandra Sekhar Korapala exemplifies the spirit of innovation in the pharmaceutical sector, with his patent contributing to improving healthcare solutions. His continued work at Merck Sharp & Dohme Corporation and collaborations with other experts underscores the importance of teamwork in advancing medical research and developing effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile